Wienerberger's Volume Growth Cuts Both Ways as Investors Await the 2027 Playbook
Published on 11/14/2026 at 21:01 | Editorial boerse-global.de
Wienerberger sold more in the third quarter of 2026 than it did a year earlier. It earned less from doing so. That single divergence — revenue up, profit down — now sits at the heart of the investment case, and the company's next two scheduled disclosures will determine whether shareholders treat it as a temporary squeeze or a structural problem.
Revenue climbed 8% year on year to EUR 1.3 billion, from EUR 1.2 billion in the third quarter of 2025, according to company figures. Operating EBITDA, however, fell to EUR 180 million from EUR 202 million. EBIT came in at EUR 67 million against EUR 110 million a year earlier, and net profit dropped to EUR 24 million from EUR 65 million, as reported by the APA news agency.
Berenberg Sticks to Its Call
Berenberg confirmed its buy rating on the stock a day after the quarterly release, keeping its price target unchanged at EUR 19.00. Neither the recommendation nor the target was adjusted.
The confirmed guidance for 2026 points to operating EBITDA of EUR 640–650 million, giving investors a near-term yardstick for the full-year results due on 17 February 2027. Those figures cover the 2026 financial year and will provide the base against which the following period is judged.
Should investors sell immediately? Or is it worth buying Wienerberger?
The €140 Million Question
Management is leaning on a strategic review that it says will deliver a recurring annual improvement in operating EBITDA of EUR 140 million from 2029, with the benefits beginning to phase in from 2027. That is a projected contribution for later years, not a gain already booked in the reported quarter — a distinction that matters when weighing the latest numbers against the longer-term ambition.
How convincingly Wienerberger connects that target to day-to-day operating performance will shape how much credit the market extends. The more clearly the company maps the path from today's cost base to the 2029 horizon, the easier it becomes to judge the plan's credibility. A detailed explanation of the individual steps carries particular weight here.
What the Outlook Must Settle
The decisive test arrives on 4 March 2027, when Wienerberger presents further details of the strategic review alongside its outlook for 2027. The central question for shareholders is straightforward: what earnings trajectory will the company set out for the coming year?
A credible improvement path would support the recovery thesis and appeal to investors willing to position early. A guidance that implies continued margin pressure would do the opposite, and the revenue growth that looks encouraging on its own would lose much of its persuasive force. The key measure is whether additional volume can once again translate into stronger operating profit.
Wienerberger at a turning point? This analysis reveals what investors need to know now.
Until then, the recent quarter offers the strongest counterargument: higher sales accompanied by a weaker operating result. Should that pattern persist, it would argue against a swift rebound in earnings quality and call for caution in setting expectations.
A Date in Paris Before the Numbers
The next confirmed investor event is the BNP Paribas Exane MidCap CEO Conference in Paris on 17 November. The February results will then allow a direct comparison with the confirmed annual guidance, giving shareholders a basis for sizing up the starting point for the year ahead. Everything beyond that hinges on the March outlook — and on whether Wienerberger can show that growth and profitability are moving in the same direction again.
Ad
Wienerberger Stock: New Analysis - 14 November
Fresh Wienerberger information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
